Researchers at ETH Zurich have refined the famous CRISPR-Cas method. Now, for the very first time, it is possible to modify dozens, if not hundreds, of genes in a cell simultaneously.
Everyone’s talking about CRISPR-Cas. This biotechnological method offers a relatively quick and easy way to manipulate single genes in cells, meaning they can be precisely deleted, replaced or modified. Furthermore, in recent years, researchers have also been using technologies based on CRISPR-Cas to systematically increase or decrease the activity of individual genes. The corresponding methods have become the worldwide standard within a very short time, both in basic biological research and in applied fields such as plant breeding.
To date, for the most part, researchers could modify only one gene at a time using the method. On occasion, they managed two or three in one go; in one particular case, they were able to edit seven genes simultaneously. Now, Professor Randall Platt and his team at the Department of Biosystems Science and Engineering at ETH Zurich in Basel have developed a process that – as they demonstrated in experiments – can modify 25 target sites within genes in a cell at once. As if that were not enough, this number can be increased still further, to dozens or even hundreds of genes, as Platt points out. At any rate, the method offers enormous potential for biomedical research and biotechnology. “Thanks to this new tool, we and other scientists can now achieve what we could only dream of doing in the past.”
Targeted, large-scale cell reprogramming
Genes and proteins in cells interact in many different ways. The resulting networks comprising dozens of genes ensure an organism’s cellular diversity. For example, they are responsible for differentiating progenitor cells to neuronal cells and immune cells. “Our method enables us, for the first time, to systematically modify entire gene networks in a single step,” Platt says.
Moreover, it paves the way for complex, large-scale cell programming. It can be used to increase the activity of certain genes, while reducing that of others. The timing of this change in activity can also be precisely controlled.
This is of interest for basic research, for example in investigating why various types of cells behave differently or for the study of complex genetic disorders. It will also prove useful for cell replacement therapy, which involves replacing damaged with healthy cells. In this case, researchers can use the method to convert stem cells into differentiated cells, such as neuronal cells or insulin-producing beta cells, or vice versa, to produce stem cells from differentiated skin cells.
The dual function of the Cas enzyme
The CRISPR-Cas method requires an enzyme known as a Cas and a small RNA molecule. Its sequence of nucleobases serves as an “address label”, directing the enzyme with utmost precision to its designated site of action on the chromosomes. ETH scientists have created a plasmid, or a circular DNA molecule, that stores the blueprint of the Cas enzyme and numerous RNA address molecules, arranged in sequences: in other words, a longer address list. In their experiments, the researchers inserted this plasmid into human cells, thereby demonstrating that several genes can be modified and regulated simultaneously.
For the new technique, the scientists did not use the Cas9 enzyme that has featured in most CRISPR-Cas methods to date, but the related Cas12a enzyme. Not only can it edit genes, it can also cut the long “RNA address list” into individual “address labels” at the same time. Furthermore, Cas12a can handle shorter RNA address molecules than Cas9. “The shorter these addressing sequences are, the more of them we can fit onto a plasmid,” Platt says.
Learn more: Revolutionising the CRISPR method
The Latest on: CRISPR
via Google News
The Latest on: CRISPR
- Gene-editing tool CRISPR wins the chemistry Nobelon October 7, 2020 at 3:11 pm
A gene-editing tool developed just eight years ago that has “revolutionized the life sciences” nabbed the 2020 Nobel Prize in chemistry.
- Gene-Editing CRISPR Pioneers Get a Well-Deserved Nobel Prizeon October 7, 2020 at 1:12 pm
On Wednesday, the Royal Swedish Academy of Sciences awarded the Nobel Prize in Chemistry to scientists Emmanuelle Charpentier and Jennifer Doudna for their pivotal roles in discovering CRISPR/Cas9, an ...
- Nobel Prize in Chemistry Goes to Discovery of 'Genetic Scissors' Called CRISPR/Cas9on October 7, 2020 at 1:09 pm
Emmanuelle Charpentier and Jennifer A. Doudna win for technology that gives scientists unprecedented abilities to change the code of life ...
- Two women just won the Nobel Prize for their work on the gene-editing technique CRISPRon October 7, 2020 at 1:04 pm
On Wednesday, a pair of female scientists became the first pair of women to solely share a Nobel Prize for a scientific discovery and become only the fifth and sixth women to win the Nobel in ...
- Crispr’s Nobel prize and IPOs both happened at lightning speedon October 7, 2020 at 1:04 pm
Emmanuelle Charpentier and biochemist Jennifer Doudna received phone calls from the secretive Nobel committee to alert them that they had made history: The scientists would share the Nobel prize in ...
- The CRISPR story: How a basic research discovery changed science and led to a Nobelon October 7, 2020 at 1:04 pm
CRISPR has accelerated the pace of scientific discovery and it is the basis of new types of medicine being tested in clinical trials.
- Two female CRISPR scientists make history, winning Nobel Prize in chemistry for genome-editing discoveryon October 7, 2020 at 12:46 pm
Emmanuelle Charpentier of the Max Planck Institute and Jennifer Doudna of the University of California have won for their CRISPR discovery.
- Gene-editing CRISPR technique can help us cut emissions from farmingon October 7, 2020 at 11:57 am
There are risks to using CRISPR, but also to not embracing it, because it will be much harder to reduce greenhouse gas emissions from food production without gene editing ...
- Pioneers of revolutionary CRISPR gene editing win chemistry Nobelon October 7, 2020 at 9:34 am
Emmanuelle Charpentier and Jennifer Doudna share the award for developing the precise genome-editing technology.
- 2 women earn Chemistry Nobel Prize for gene-editing tool CRISPRon October 7, 2020 at 8:58 am
Nobel Prize in chemistry went to two women who developed a gene-editing tool called CRISPR-Cas9, which snips DNA like a pair of molecular scissors. The technique "has not ...
via Bing News